vTv Therapeutics Inc. (VTVT) P/B ratio
Only 2 fiscal years of P/B ratio are on record here for vTv Therapeutics Inc. (VTVT); a history needs at least 3. vTv Therapeutics Inc. (VTVT) trades at 2.3× its book value per share at the end of fiscal 2025. Figures as of 18 Nov 2026, 10:53 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- P/B ratio today
- 2.3×
- P/B ratio, fiscal 2025
- 5.2×
- Change on fiscal 2024
- −20.0%
- Fiscal years on record
- 22024–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Not enough data
A history of P/B ratio needs at least 3 fiscal years; 2 are on record here for vTv Therapeutics Inc.. Nothing is estimated to fill the gap. What is on record is in the table below.
vTv Therapeutics Inc. P/B ratio, year by year
| Fiscal year | P/B ratio | Change | Year ended | Share price at year-end | Book value per share |
|---|---|---|---|---|---|
| Today | 2.3× | — | $17.29 | — | |
| 2025 | 5.2× | 20.0% down | $39.99 | $7.65 | |
| 2024 | 6.5× | — | $13.81 | $2.11 | |
| 2023 | — | — | $11.50 | -$11.84 | |
| 2022 | — | — | $26.52 | -$5.74 | |
| 2021 | — | — | $39.80 | — | |
| 2020 | — | — | $74.40 | — | |
| 2019 | — | — | $68.00 | — | |
| 2018 | — | — | $106.00 | — | |
| 2017 | — | — | $240.40 | — | |
| 2016 | — | — | $193.20 | — | |
| 2015 | — | — | $272.40 | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.
How to read it
It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.
vTv Therapeutics Inc., figure by figure
- vTv Therapeutics Inc. market cap
- vTv Therapeutics Inc. revenue
- vTv Therapeutics Inc. earnings
- vTv Therapeutics Inc. earnings per share (EPS)
- vTv Therapeutics Inc. P/E ratio
- vTv Therapeutics Inc. P/S ratio
- vTv Therapeutics Inc. free cash flow
- vTv Therapeutics Inc. operating margin
- vTv Therapeutics Inc. dividend
- vTv Therapeutics Inc. shares outstanding
- vTv Therapeutics Inc. total debt
- vTv Therapeutics Inc. cash on hand
- vTv Therapeutics Inc. total assets
- vTv Therapeutics Inc. return on equity (ROE)
- vTv Therapeutics Inc. return on invested capital (ROIC)
vTv Therapeutics Inc. (VTVT) overview: price, valuation and scorecard
vTv Therapeutics Inc. P/B ratio: questions and answers
What is vTv Therapeutics Inc.'s P/B ratio?
vTv Therapeutics Inc. (VTVT) trades at 2.3× its book value per share at the end of fiscal 2025.
How is vTv Therapeutics Inc.'s P/B ratio calculated?
The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For vTv Therapeutics Inc. it is on record here for 2 fiscal years, 2024 to 2025.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/B ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Piotroski F-score: the nine tests and what they show
The Piotroski F-score is a 0–9 count of simple accounting tests a company passes: four on profitability, three on debt, liquidity and share issuance, two on operating efficiency. Joseph Piotroski's 2000 paper found that among cheap, high book-to-market stocks, high scorers went on to beat low scorers. It is a screen of financial health, not a valuation.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “vTv Therapeutics Inc. (VTVT) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/VTVT/pb-ratio
Underlying data: the company's filings with the SEC and Yahoo Finance.